Profil
Yang Shen is currently Chief Medical Officer at Ocumension Therapeutics since 2024.
Formerly, Ms. Shen was Medical Director at Ocumension Therapeutics and Manager of the Medical Information Section at Santen Pharmaceutical (China) Co. Ltd. from 2015 to 2019.
Ms. Shen completed an undergraduate degree at Zhengzhou University in 2005 and a doctorate at China Pharmaceutical University in 2010.
Postes actifs de Yang Shen
| Sociétés | Poste | Début |
|---|---|---|
| OCUMENSION THERAPEUTICS | Directeur Technique/Scientifique/R&D | 01/01/2024 |
Anciens postes connus de Yang Shen
| Sociétés | Poste | Fin |
|---|---|---|
Santen Pharmaceutical (China) Co. Ltd.
Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Corporate Officer/Principal | 01/03/2019 |
| OCUMENSION THERAPEUTICS | Corporate Officer/Principal | - |
Formation de Yang Shen
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Zhengzhou University
Zhengzhou University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
China Pharmaceutical University
China Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Santen Pharmaceutical (China) Co. Ltd.
Santen Pharmaceutical (China) Co. Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and wholesales ophthalmic pharmaceuticals | Health Technology |
Ocumension Therapeutics
Ocumension Therapeutics Miscellaneous Commercial ServicesCommercial Services Operates as an ophthalmic pharmaceutical platform company that develops drugs | Commercial Services |
















